Authors: Bingham, S Davey, PT Babbs, AJ Irving, EA Sammons, MJ Wyles, M Jeffrey, P Cutler, L Riba, I Johns, A Porter, RA Upton, N Hunter, AJ Parsons, AA

Citation: S. Bingham et al., Orexin-A, an hypothalamic peptide with analgesic properties, PAIN, 92(1-2), 2001, pp. 81-90

Authors: Barone, FC Irving, EA Ray, AM Lee, JC Kassis, S Kumar, S Badger, AM Legos, JJ Erhardt, JA Ohlstein, EH Hunter, AJ Harrison, DC Philpott, K Smith, BR Adams, JL Parsons, AA

Citation: Fc. Barone et al., Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia, MED RES REV, 21(2), 2001, pp. 129-145

Authors: Barone, FC Irving, EA May, AM Lee, JC Kassis, S Kumar, S Badger, AM White, RF McVey, MJ Legos, JJ Erhardt, JA Nelson, AH Ohlstein, EH Hunter, AJ Ward, K Smith, BR Adams, JL Parsons, AA

Citation: Fc. Barone et al., SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia, J PHARM EXP, 296(2), 2001, pp. 312-321

Authors: Irving, EA Bentley, DL Parsons, AA

Citation: Ea. Irving et al., Assessment of white matter injury following prolonged focal cerebral ischaemia in the rat, ACT NEUROP, 102(6), 2001, pp. 627-635

Authors: Irving, EA Hadingham, SJ Roberts, J Gibbons, M Chabot-Fletcher, M Roshak, A Parsons, AA

Citation: Ea. Irving et al., Decreased nuclear factor-kappa B DNA binding activity following permanent focal cerebral ischaemia in the rat, NEUROSCI L, 288(1), 2000, pp. 45-48

Authors: Irving, EA Barone, FC Reith, AD Hadingham, SJ Parsons, AA

Citation: Ea. Irving et al., Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat, MOL BRAIN R, 77(1), 2000, pp. 65-75